Clinical Trial Update: Effectiveness Allopurinol Topical Agent Prevention Capecitabine-induced Hand-foot Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the effectiveness of a topical allopurinol formulation to prevent capecitabine-induced hand-foot syndrome; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hand-foot Syndrome

Drugs mentioned

• Allopurinol topical agent (allopurinol topical formulation)

Snippet

Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | Conditions: Hand-foot Syndrome | Phase 2 | Status: COMPLETED